By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – WaferGen reported after the close of the market Monday that revenues for the second quarter slid nearly 10-fold year over year due to an "absence of sales" of its flagship real-time PCR platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.